Deals
Nestle Said to Plan Pfizer Asset Sales to Sooth Regulator
This article is for subscribers only.
Nestle SA may sell as much as $1.8 billion of the infant-nutrition assets it is buying from Pfizer Inc. as antitrust concerns in countries such as Mexico force divestitures, said people with knowledge of the matter.
About 10 percent to 15 percent of the $11.9 billion unit may be put up for sale by Nestle, said the people, who declined to be identified because the discussions are private. The Vevey, Switzerland-based company has overlapping baby-food businesses in more than a dozen countries and may eventually have to sell divisions in places including Australia, Venezuela and Thailand, the people said.